Levi & Korsinsky is commencing an investigation into the Board of Directors of Vision-Sciences, Inc. (“Vision-Sciences” or “the Company”) (NasdaqCM:VSCI) in connection with possible breaches of fiduciary duty and other violations of state law in connection with the merger of the Company to Uroplasty, Inc. (NasdaqCM:UPI).

Click here to learn more about the investigation: http://zlk.9nl.com/vision-sciences-vsci.

Upon completion of the merger, Vision-Sciences shareholders will own only 37.5% of the post-merger entity. The investigation concerns whether the Board of Vision-Sciences is acting in shareholders’ best interest by agreeing to this transaction. The new company will conduct business as Cogentix Medical, Inc., and its Board will consist of 5 representatives from Uroplasty’s existing board and just three representatives from Vision-Sciences’ existing board.

If you own Vision-Sciences common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/vision-sciences-vsci.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax: 866-367-6510www.zlk.com

Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cognyte Software Charts.
Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cognyte Software Charts.